Interleukin-1 and Tumor Necrosis Factor Receptor Signaling Is Not Required for Bacteria-Induced Osteoclastogenesis and Bone Loss but Is Essential for Protecting the Host from a Mixed Anaerobic Infection
Open Access
- 31 December 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (6) , 2145-2152
- https://doi.org/10.1016/s0002-9440(10)65532-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.Journal of Clinical Investigation, 1997
- Bone‐resorptive cytokine gene expression in periapical lesions in the ratOral Microbiology and Immunology, 1997
- Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal CentersScience, 1996
- Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy periodEndocrinology, 1995
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994
- Role of cytokines and inflammatory mediators in tissue destructionJournal of Periodontal Research, 1993
- Two TNF receptorsImmunology Today, 1992
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Influence of combinations of oral bacteria on periapical tissues of monkeysEuropean Journal of Oral Sciences, 1982